Christoph Welp

Chief Operating Officer (COO)

Bonn, North Rhine-Westphalia, Germany

Professional Overview
Christoph Welp is an accomplished and versatile business leader with over 15 years of experience in the medical device industry. As the Chief Operating Officer (COO) of WallabyPhenox, he is responsible for driving operational excellence, streamlining processes, and ensuring the company's continued growth and profitability. With a strong technical background and a keen understanding of global markets, Christoph is adept at aligning strategic objectives with efficient, data-driven decision-making.

Experience Summary

Current Role
As the COO of WallabyPhenox, Christoph is responsible for overseeing the company's day-to-day operations, including production, supply chain management, and quality control. Since joining the company in 2024, he has implemented lean manufacturing principles, optimized inventory management, and spearheaded the development of new production facilities to meet growing global demand. Under his leadership, the company has achieved a 20% increase in operational efficiency and a 15% reduction in manufacturing costs.

Career Progression
Prior to his current role, Christoph held several senior positions within the medical device industry, including Managing Director of Phenox Ltd. in Ireland, General Manager for Germany and Ireland at Phenox, and various marketing and business development roles at MicroVention-Terumo and Sequent Medical. Throughout his career, he has demonstrated a strong ability to drive innovative solutions, foster cross-functional collaboration, and deliver measurable results.

Academic Background
Christoph holds a Master's degree in Mechanical Engineering from the Technical University of Munich, where he specialized in biomedical engineering and medical device design. He is also a certified Lean Six Sigma Black Belt, with a proven track record of implementing process improvements to enhance operational efficiency.

Areas of Expertise

• Operational and supply chain management

• Quality control and process optimization

• Global market expansion and strategic partnerships

• Cross-functional team leadership and collaboration

• Medical device design and development

• Regulatory compliance and quality assurance

Professional Impact
Under Christoph's leadership, Phenox Ltd. in Ireland achieved a 30% increase in production capacity and a 25% reduction in lead times, positioning the company as a preferred supplier in the European market. Additionally, his work in leading the integration of Phenox's German and Irish operations resulted in a 15% reduction in overhead costs and improved service delivery to customers across the EMEA region.

Conclusion
With his extensive industry experience, strong technical expertise, and proven track record of driving operational excellence, Christoph Welp is a valuable asset to WallabyPhenox. As the company's COO, he is poised to further enhance the organization's global competitiveness, optimize its operational efficiency, and contribute to its continued success in the evolving medical device landscape.